Baseline serum phosphatidylcholine plasmalogen concentrations are inversely associated with incident myocardial infarction in patients with mixed peripheral artery disease presentations

Joseph V. Moxon, Rhondda E. Jones, Gerard Wong, Jacquelyn M Weir, Natalie A Mellett, Bronwyn A. Kingwell, Peter J. Meikle, Jonathan Golledge

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background and aims Despite current best care, patients with peripheral artery disease (PAD) remain at high risk of myocardial infarction, and biomarkers to more accurately assess cardiovascular risk are needed. This study assessed the relationship between the serum lipidome and incident myocardial infarction in a cohort of PAD patients. Methods 265 PAD patients were followed up for a median of 23 months, during which 18 people suffered a myocardial infarction. Fasting serum concentrations of 332 lipid species were measured via mass spectrometry and their association with incident myocardial infarction was assessed via Cox regression. Secondary analyses investigated prognostic potential of specific lipid species. Results Total serum concentrations of alkyl-phosphatidylcholine and alkenylphospatidylcholine (plasmalogen) lipids were inversely associated with incident myocardial infarction after adjusting for multiple testing (hazards ratio (95% confidence intervals): 0.43 (0.24–0.74); p = 0.032; and 0.28 (0.14–0.56), p = 0.010, respectively). Specifically, 10 alkenylphosphatidylcholine species and 6 alkyl-phosphatidylcholine species were negatively associated with incident myocardial infarction after adjusting for traditional risk factors and correcting for multiple testing (hazards ratios ranging from 0.07 to 0.51, p < 0.05). Incorporation of serum phosphatidylcholine plasmalogen species PC(P-40:6) concentration within analyses designed to determine subsequent myocardial infarction incidence led to an improvement in predictive accuracy compared to traditional risk factors alone. Conclusions Serum concentrations of phosphatidylcholine plasmalogens and alkyl-phosphatidylcholines were negatively associated with incident myocardial infarction and have potential to act as novel prognostic markers in at-risk populations.

Original languageEnglish
Pages (from-to)301-308
Number of pages8
JournalAtherosclerosis
Volume263
DOIs
Publication statusPublished - 1 Aug 2017
Externally publishedYes

Keywords

  • Biomarker
  • Myocardial infarction
  • Peripheral artery disease
  • Plasmalogen

Cite this

@article{c79c8fa684ef49a7add3d7146ad1026d,
title = "Baseline serum phosphatidylcholine plasmalogen concentrations are inversely associated with incident myocardial infarction in patients with mixed peripheral artery disease presentations",
abstract = "Background and aims Despite current best care, patients with peripheral artery disease (PAD) remain at high risk of myocardial infarction, and biomarkers to more accurately assess cardiovascular risk are needed. This study assessed the relationship between the serum lipidome and incident myocardial infarction in a cohort of PAD patients. Methods 265 PAD patients were followed up for a median of 23 months, during which 18 people suffered a myocardial infarction. Fasting serum concentrations of 332 lipid species were measured via mass spectrometry and their association with incident myocardial infarction was assessed via Cox regression. Secondary analyses investigated prognostic potential of specific lipid species. Results Total serum concentrations of alkyl-phosphatidylcholine and alkenylphospatidylcholine (plasmalogen) lipids were inversely associated with incident myocardial infarction after adjusting for multiple testing (hazards ratio (95{\%} confidence intervals): 0.43 (0.24–0.74); p = 0.032; and 0.28 (0.14–0.56), p = 0.010, respectively). Specifically, 10 alkenylphosphatidylcholine species and 6 alkyl-phosphatidylcholine species were negatively associated with incident myocardial infarction after adjusting for traditional risk factors and correcting for multiple testing (hazards ratios ranging from 0.07 to 0.51, p < 0.05). Incorporation of serum phosphatidylcholine plasmalogen species PC(P-40:6) concentration within analyses designed to determine subsequent myocardial infarction incidence led to an improvement in predictive accuracy compared to traditional risk factors alone. Conclusions Serum concentrations of phosphatidylcholine plasmalogens and alkyl-phosphatidylcholines were negatively associated with incident myocardial infarction and have potential to act as novel prognostic markers in at-risk populations.",
keywords = "Biomarker, Myocardial infarction, Peripheral artery disease, Plasmalogen",
author = "Moxon, {Joseph V.} and Jones, {Rhondda E.} and Gerard Wong and Weir, {Jacquelyn M} and Mellett, {Natalie A} and Kingwell, {Bronwyn A.} and Meikle, {Peter J.} and Jonathan Golledge",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.atherosclerosis.2017.06.925",
language = "English",
volume = "263",
pages = "301--308",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier",

}

Baseline serum phosphatidylcholine plasmalogen concentrations are inversely associated with incident myocardial infarction in patients with mixed peripheral artery disease presentations. / Moxon, Joseph V.; Jones, Rhondda E.; Wong, Gerard; Weir, Jacquelyn M; Mellett, Natalie A; Kingwell, Bronwyn A.; Meikle, Peter J.; Golledge, Jonathan.

In: Atherosclerosis, Vol. 263, 01.08.2017, p. 301-308.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Baseline serum phosphatidylcholine plasmalogen concentrations are inversely associated with incident myocardial infarction in patients with mixed peripheral artery disease presentations

AU - Moxon, Joseph V.

AU - Jones, Rhondda E.

AU - Wong, Gerard

AU - Weir, Jacquelyn M

AU - Mellett, Natalie A

AU - Kingwell, Bronwyn A.

AU - Meikle, Peter J.

AU - Golledge, Jonathan

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Background and aims Despite current best care, patients with peripheral artery disease (PAD) remain at high risk of myocardial infarction, and biomarkers to more accurately assess cardiovascular risk are needed. This study assessed the relationship between the serum lipidome and incident myocardial infarction in a cohort of PAD patients. Methods 265 PAD patients were followed up for a median of 23 months, during which 18 people suffered a myocardial infarction. Fasting serum concentrations of 332 lipid species were measured via mass spectrometry and their association with incident myocardial infarction was assessed via Cox regression. Secondary analyses investigated prognostic potential of specific lipid species. Results Total serum concentrations of alkyl-phosphatidylcholine and alkenylphospatidylcholine (plasmalogen) lipids were inversely associated with incident myocardial infarction after adjusting for multiple testing (hazards ratio (95% confidence intervals): 0.43 (0.24–0.74); p = 0.032; and 0.28 (0.14–0.56), p = 0.010, respectively). Specifically, 10 alkenylphosphatidylcholine species and 6 alkyl-phosphatidylcholine species were negatively associated with incident myocardial infarction after adjusting for traditional risk factors and correcting for multiple testing (hazards ratios ranging from 0.07 to 0.51, p < 0.05). Incorporation of serum phosphatidylcholine plasmalogen species PC(P-40:6) concentration within analyses designed to determine subsequent myocardial infarction incidence led to an improvement in predictive accuracy compared to traditional risk factors alone. Conclusions Serum concentrations of phosphatidylcholine plasmalogens and alkyl-phosphatidylcholines were negatively associated with incident myocardial infarction and have potential to act as novel prognostic markers in at-risk populations.

AB - Background and aims Despite current best care, patients with peripheral artery disease (PAD) remain at high risk of myocardial infarction, and biomarkers to more accurately assess cardiovascular risk are needed. This study assessed the relationship between the serum lipidome and incident myocardial infarction in a cohort of PAD patients. Methods 265 PAD patients were followed up for a median of 23 months, during which 18 people suffered a myocardial infarction. Fasting serum concentrations of 332 lipid species were measured via mass spectrometry and their association with incident myocardial infarction was assessed via Cox regression. Secondary analyses investigated prognostic potential of specific lipid species. Results Total serum concentrations of alkyl-phosphatidylcholine and alkenylphospatidylcholine (plasmalogen) lipids were inversely associated with incident myocardial infarction after adjusting for multiple testing (hazards ratio (95% confidence intervals): 0.43 (0.24–0.74); p = 0.032; and 0.28 (0.14–0.56), p = 0.010, respectively). Specifically, 10 alkenylphosphatidylcholine species and 6 alkyl-phosphatidylcholine species were negatively associated with incident myocardial infarction after adjusting for traditional risk factors and correcting for multiple testing (hazards ratios ranging from 0.07 to 0.51, p < 0.05). Incorporation of serum phosphatidylcholine plasmalogen species PC(P-40:6) concentration within analyses designed to determine subsequent myocardial infarction incidence led to an improvement in predictive accuracy compared to traditional risk factors alone. Conclusions Serum concentrations of phosphatidylcholine plasmalogens and alkyl-phosphatidylcholines were negatively associated with incident myocardial infarction and have potential to act as novel prognostic markers in at-risk populations.

KW - Biomarker

KW - Myocardial infarction

KW - Peripheral artery disease

KW - Plasmalogen

UR - http://www.scopus.com/inward/record.url?scp=85024361894&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2017.06.925

DO - 10.1016/j.atherosclerosis.2017.06.925

M3 - Article

VL - 263

SP - 301

EP - 308

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

ER -